- Scientists from UCLA’s School of Medicine genetically engineered tomatoes to product 6F–a peptide that mimics the chief protein in HDL (“good cholesterol”). The tomatoes were consumed by mice that did not have the ability to purge LDL (“bad cholesterol”) from their blood.
- The mice that ate the genetically engineered tomatoes “had less inflammation and reduced atherosclerosis (plaque build-up in the arteries)” and had higher levels of HDL (details of effects on mice available through link below)
- Alan M. Fogelman, M.D., senior author of the study and director of the Atherosclerosis Research Unit in the Geffen School of Medicine at UCLA notes the significance of this study:
Source: American Heart Association, Genetically engineered tomatoes decrease plaque build-up in mice
“To our knowledge this is the first example of a drug with these properties that has been produced in an edible plant and is biologically active when fed without any isolation or purification of the drug”